Clinically Proven Health Benefits of «Bifilife Forte»

Probiotic strains that form consortium “Bifilife Forte” are selected in a way that represents a symbiosis of microorganisms, which co-exist without oppressing each other and increase the probiotic properties specific to each of the five strains.

The consortium “Bifilife Forte” is more resistant to the damaging factors of aggressive environments of the gastrointestinal tract and thus improves its colonizing activity during passage of the digestive tract, and has a pronounced antioxidant activity and strong probiotic effect, that are manifested in in vivo and in vitro conditions.

The consortium actively multiplies in environments of different composition.

Studies have shown that strains of bifidobacterium that form “Bifilife Forte” don't show antagonism to each other when co-cultured in thioglycolic media or corn-lactose media.

The consortium “Bifilife Forte” capable of utilizing the free amino acids in aseptic fat free milk such as valine, methionine, alanine, arginine, isoleucine, glycine.

The consortium exhibits antagonistic activity toward the test cultures, that were obtained from L.A. Tarasevich State Research Institute for Standardization and Control of Medical Biological Preparations: E. coli B-125, Staphylococcus aureus 209P, Shigella sonnei, Shigella flexneri, which are most often the cause of food poisoning arising from the consumption of dairy products. Also, “Bifilife Forte” has a pronounced antagonistic activity to pathogenic and opportunistic pathogenic microorganisms: E. coli, Candida albicans, Proteus mirabilis, Proteus vulgaris, Klebsiella pneumoniae, Citrobacter freundii, Bacillus subtilis.

An increase in the range of species of used probiotic cultures leads to strengthening antagonistic action of dairy products on the pathogens of intestinal infections.

Research of the consortium showed resistant to the highest concentrations of the following antibiotics: amikacin, tetracycline, benzylpenicillin, gentamicin, kanamycin, ofloxacin, streptomycin. High activity of acid and antibiotic resistance to a wide range of basic antibiotics, promotes the effective restoration of normal intestinal microflora in the course of antibiotic therapy.

Consumption of foods that contain the consortium promotes the colonization of the intestinal mucosa, displacement of pathogenic and opportunistic pathogenic microflora, correction of intestinal dysbiosis and restore bifidoflora.

The main production and useful feature of the consortium, which distinguishes it from other analogous products is expressed superoxide dismutase activity, which is 24.9 units/mg protein in the microbial biomass.

Vitamin production of the most vitamins of group B is one of many probiotics' health benefits. The table below shows what probiotic type of the consortium is involved in different vitamin production:

According to Boris Shenderov, DmedSc, Professor, Head of probiotics and functional food products at Gabrichevskiy Moscow Research Institute of Epidemiology and Microbiology, president of the Russian Association “Epidbiomed”: consumption of food enriched with “Bifilife Forte” creates favorable conditions for the selection of those types of probiotic that are in the deficiency in the human intestine, and clinical studies of “Bifilife Forte” showed that the consumption of food enriched with “Bifilife Forte” promotes more rapid clinical improvement in cases of the gastrointestinal tract diseases, liver diseases, urogenital system diseases, wound infection and patients with cancer.

Optimal development of the immune system since birth depends on the development and composition of the indigenous microbiota. Products enriched with «Bifilife Forte» consumed to modulate and improve the gut microbiota balance and what will boost the immune system as a result.